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Fibrinogen and Lp(a) in Ischemic Heart Disease.
The Quebec Cardiovascular Study
Regulation of Glucose Utilization by L-Carnitine
in Cardiac Myocytes
Salah Abdel-aleem, Mohamed Sayed-Ahmed, Steven Hendrickson, James SI.
louis, Mark P. Anstadt, James E. lowe. Duke University Medical Center, Durham,
North Carolina, 27710
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Values are presented as the mean ± SD of at least three different exper-
iments. Asterisks represent a p < 0.05 of the effect of carnitine vs control.
These data show that L-carnitine stimulates PDH activity by 50%. However,
the flux of acetyl-CoA and glucose through Kreb's cycle was significantly de-
creased by this compound. These results suggest that L-carnitine enhances
the removal of acetyl-CoA produced from glucose metabolism out of the
mitochondrial matriX, thereby, activating the PDH complex.
L-Carnitine has been shown to protect the myocardium from ischemic in-
jury, and also improves cardiac function in cardiomyopathies associated with
carnitine deficiency and diabetes. However, the exact mechanism whereby
carnitine exerts its effect is not fully understood. The present study was de-
signed to investigate the effect of carnitine on the regulation of glucose uti-
lization in the heart. These studies were performed bl determining the effect
of L-carnitine (5 mM) on the 14C02 release from [1 J C]pyruvate (an index of
pyruvate dehydrogenase complex, PDH), [2-14C]pyruvate (an index of acetyl-
CoA flux through Kreb's cycle). and [6_14C]glucose (an index of the oxidative
utilization of glucose). in rat myocytes.
Bernard Cantin, Sital Moorjani, Jean-Pierre Despres, Paul-J. Lupien, Gilles
R. Dagena is. Upid Research Center, !..Eval University. Quebec, Canada; Department of
Medicine, University ofMontreal, Montreal, Canada
In an ongoing ischemic heart disease (IHD) risk factor study, plasma lipid,
Lp(a) and fibrinogen measurements were performed in 2125 men aged 45-
75 years in 1985. The subjects were followed until September 1st 1990. Dur-
ing that period, 116 first IHD events were documented (myocardial infarction,
angina and IHD death). Subjects with IHD were older (59 ± 8 vs 56 ± 7 years;
p < 0.0011. had higher systolic pressure (137 ± 17 vs 130 ± 17 mmHg; p <
0.001). a higher frequency of smoking ~20 cig/d (32 vs 23%; p = 0.027) and
a higher prevalence of diabetes (16 vs 4%; p < 0.001). Total cholesterol (235
± 41 vs 221 ± 39 mg/dL; p < 0.001), LDL-cholesterol (162 ± 37 vs 149 ± 35
mg/dL; p < 0.001), Lp{a) (41.0 ± 45.9 vs 32.7 ± 34.9 mg/dL; p = 0.014) and
fibrinogen (3.89 ± 0.81 vs 3.55 ± 0.75 gil; p < 0.001) levels were higher in
IHD while HDL-cholesterol was lower (37 ± 9 vs 40 ± 10 mg/dL; p ~ 0.005).
Adjusted risk ratios were significantly increased in the third fibrinogen terti Ie
(2.4 ± 0.3; P < 0.001) but not in the second fibrinogen nor in any Lp(a) tertile.
In order to further ascertain the role of fibrinogen and Lp(al. subjects were
assigned to one of four groups according to fibrinogen and Lp(a) levels. The
cutoff point for fibrinogen was the median of the distribution (3.52 gil) and
25 mg/dl for Lp(a).
Group 1: fibrinogen <3.52 gil and Lp(a) <25 mg/dL;
Group 2: fibrinogen <3.52 gil and Lp(a) ~25 mg/dL;
Group 3: fibrinogen ~3.52 gil and Lp(a) <25 mg/dL;
Group 4: fibrinogen ~3.52 gil and Lp(a) ~25 mg/dL.
on polyacrylamide (PAGE; 5 to 16% gradient) and agarose gel electrophore-
sis (0.8% in Tris-HCL buffer). No significant increase was observed in the
basal concentration of MDA between LDL from H and controls (0.8 ± 0.12
and 0.9 ± 0.15 nmoles of MDAlmg of protein, respectively). Instead, afteroxi-
dation MDA was 35.1 ± 4.5* nmoles/mg of protein LDL from H, and 23.5±4.1
in controls (*p < 0.05). PAGE confirmed the purity of LDL. present as an intact
apolipoprotein B100(apo-B 100 ). When oxidized LDL was run on PAGE an ex-
tensive apo-B100 fragmentation, replaced by lower fragments ranging from
97.400 to 205.000 m.w., was only observed in LDL from H but not in controls
in our experimental conditions. MDA content after oxidation of LDL corre-
lated well with the loss of intact apo-B 100. Finally, the relative LDL mobility
on agarose gel was evaluated. This assay allows to detect changes in elec-
tric charge induced by oxidation. Basal LDL from H and controls migrated as
homogeneous bands to 1.2 + 0.2 and 1.1 ± 0.2 cm from the origin. In con-
trast, oxidized LDL from H migrated to 2.1 ± 0.3* cm from the origin while
those of controls migrated to 1.5 ± 0.2 (*p < 0.05). Thus, in FH LDL appear
to be more susceptible to oxidationin vitro; the indices for LDL oxidizability
were all significantly different from those of controls. This phenomenon may
be an important additional mechanism of atherogenesis in homozigous FH.
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In Vitro Inhibition of Smooth Muscle Cell
Proliferation by Sterol 27-Hydroxylase
Metabolites
B.M. Steinberg, E.A. Grossi, J. Greenberg, C. Bizekis, w.J. O'Connor, A. Reiss,
A.C. Galloway, N.B. Javitt. New York University Medical Center, New York, NY
These findings were similar in men and women. Multivariate adjustment
for age, gender, body mass index, diabetes, smoking, alcohol intake, and use
of antihypertensive medication did not alter the results.
Conclusion: Decreasing LDL-C levels are associated with decreasing lev-
els of hemostatic risk factors. These findings support the hypothesis that
lipid lowering therapy may reduce clinical events by reducing thrombotic
tendency.
greater degree than it reduces stenosis severity suggest beneficial effects
other than plaque regression. To determine if a favorable lipid profile is asso-
ciated with decreased thrombotic tendency, we determined the relationship
between two hemostatic risk factors, fibrinogen and plasminogen activator
inhibitor (PAI-l), and LDL cholesterol (LDL-C) in 1,878 subjects free of cardio-
vascular disease in the Framingham Offspring Study. The subjects studied
ranged from those with hypobetalipoproteinemia, a condition characterized
by LDL-C :s 70 mg/dl, and a low incidence of thrombosis and coronary heart
disease, to other LDL-C levels grouped by NCEP guidelines.
Claudio Napoli, Alfredo Postiglione 1, Giuseppe Palumbo 2, Antonio Ruocco 1,
Giuseppe Ambrosio, Mario Condorelli, Mario Mancini 1, Massimo Chiariello. Div
of Cardiology. "Federico II" School of Medicine, University ofNaples, Italy; 1 Inst of
Internal Medicine and Metabolic Diseases, "Federico II" School of Medicine, University
of Naples, Italy; 2 Dept. of Molecular Pathology. "Federico II" School of Medicine,
University ofNaples, Italy
Familial hypercholesterolemia (FH) was the first genetic disorder recognized
to cause myocardial infarction. Homozigotes (H) inherit two mutant genes
at the low density lipoprotein (LDL) receptor locus, and as a result of the
increased levels and prolonged residence time of LDL in plasma, there is
a strong tendency toward accumulation of LDL in the arterial wall, causing
early atherogenesis. It has been shown that LDL might undergo oxidation be-
fore it can be taken up by macrophages and it become foam cells. Thus, one
additional explanation for atherogenesis in FH may be the extent to which
LDL is susceptible to oxidation. We selected 8 homozigous FH pts (mean
total-cholesterol 825 ± 70 mg/dl) matched with 8 healthy subjects to inves-
tigate the LDL oxidizability. Skin fibroblast cultures showed that one patient
was receptor negative, while others were receptor-defective. LDL were iso-
lated from serum by ultracentrifugations in KBr. Purified LDL was exposed to
oxygen radicals generated by the xanthine/xanthine oxidase reaction (2 mM
and 100 mU, respectively for 18 hs at 37' C). Malonildihaldehyde (MDAI con-
tent was evaluated by the thiobarbiturate method. LDL analysis was carried
Sterol 27-hydroxylase controls side chain oxidation of bile acids and is
found in vascular endothelial cells. Two metabolites of this oxidation are 27-
hydroxycholesterol (27-0H). which inhibits smooth muscle cell (SMC) pro-
liferation in vivo, and 3tJ-hydroxy-5-cholestenoic acid (C27). We quantified
the inhibitory capacity of both these compounds in vitro using a rabbit aor-
tic SMC preparation. Early passage SMC were grown to confluence, plated
at a density of 5,000 cells/well, and synchronized for 24 hrs. The cells were
then grown in the presence of Dulbecco's modified Eagle's medium with 5%
delipidated fetal calf serum alone (control). in increasing concentrations (1 0,
20,30 ,.,M) of 27-0H and C27 dissolved in 2-hydroxypropyl-tJ-cyciodextrin
(HPBCD). in an equivalent amount of HPBCD alone (control), and in colchicine
(1 mg/dl). Cell proliferation at 24 hrs was measured via formazans formation
from the tetrazolium salt MTS by absorbance at OD 490 nm There was no
significant difference in absorbance between the control and the HPBCD (ab-
sorbance 0.402 ± 0,037 vs 0.400 ± 0.057) or 10 ,.,M concentration 27-0H
(0.383 ± 0.0561 or C27 (0.374 ± 0.022) groups. However, concentrations of
20 and 30 ,.,M of 27-0H produced a significant growth inhibition (0.362 ±
0.030 and 0.350 ± 0.021, P < 0.01) compared to controls, as did C27 at 20
and 30 ,.,M (0.357 ± 0.22 and 0.344 ± 0.28, P < 0.01), while the colchicine
group exhibit the greatest inhibition (0.125 ± 0021). Thus 27-0H and C27
demonstrated a dose response growth inhibition of SMC, and endothelial
sterol 27-hydroxylase may play an important role in modulation of myointi-
mal hyperplasia during the atherosclerotic process.
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Conclusion; Urinary 8-isoprostane is elevated in smokers and may provide
a sensitive, specific and noninvasive method for assessment of in vivo lipid
peroxidation. Further studies are indicated to determine whether elevated
8-isoprostane identifies individuals at risk for developing atherosclerosis.
Use of the Internet and World Wide Web for
Dissemination and Collection of Midwest
Pediatric Pacemaker Registry Information
of effort to complete. The prototype system is undergoing alpha testing. For
the prototype stage, all interpretations of clinical records are overread by a
clinical cardiologist prior to transmission to the user.
Conclusions: This system may be beneficial in increasing the level of care
of patients in the rural setting by providing the ECG interpretation expertise
of an experienced cardiologist to rural practitioners on demand, which may
also lead to decreasing the cost of rural health care. In addition, the system
may be modified for applications in other health care domains.
Gerald A. Serwer, Julie Morris. Univ. of Michigan, Ann Arbor, MI
The Midwest Pediatric Pacemaker registry which provides a large data-base
of information concerning pacemaker implantation in children relies upon
printed articles and meeting presentations for dissemination of collected in-
formation and upon member institutions to complete and mail printed forms
for data submission. This process increases the time necessary for data
submission and slows dissemination of pooled data to the pediatric pacing
community. With increasing Internet access by centers involved in pediatric
pacing, and the development of the World Wide Web (WWW), use of the
WWW was explored to evaluate its potential for information dissemination
and acquisition. Hypertext mark-up language (HTML) documents of compos-
ite Registry statistics, patient demographics with initial implantation indica-
tion, and generator implantation and electrode utilization information were
made available on the Internet by publishing it on the WWW. Documents
presented data both in textual and graphical form and were organized by
topic on different pages to allow selective access directly the data needed.
The graphs presented can be downloaded in GIF format. Use of the easily
prepared HTML documents allows for frequent updating of information with
rapid access by centers involved in pediatric pacing. In addition utilizing the
forms capability of WWW browsers, Pacemaker Registry information can be
submitted on-line The form page is displayed and the information directly
entered. Information entry is accomplished byfilling in character fields, check
boxes and free text fields. The form is then automatically sent to the WWW
server which forwards it to the Registry Director for database entry. It is never
stored on the public access WWW server, ensuring patient confidentiality.
For users without a forms capable WWW browser, a file containing the sub-
mission forms is also provided that can be downloaded. Use of the WWW
and Internet provides more rapid dissemination and collection of Registry in-
formation shortening the period between data collection and data review by
centers involved in pediatric pacing which should improve the quality of care
delivered to children requiring permanent pacing. Use of WWW can provide
a rapid means of medical data dissemination and communication.
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P-Value
P ~ 00021.55 ± 022
2.77 ± 0.21
Mean ± SEM
8-Epi-Prostaglandin F2a (8-lsoprostane), a Novel
Marker of Lipid Peroxidation, is Elevated and
Inversely Correlated to Serum Antioxidant
Vitamins in Smokers
8-lsoprostane
Values ~ /.I-g/24 hours
Nonsmokers
Smokers
Emile R. Mohler, Pam McClelland, David R. Hathaway, Peter Reaven. Krannert
Institute of Cardiology, Indiana University, Indianapolis, IN; University of California San
Diego, La Joffa, CA
Oxidative modification of lipoproteins is thought to be an essential event
in atherosclerosis. Current methods of quantifying lipid peroxidation in vivo
are technically difficult andlor nonspecific. A simple, clinically reliable test is
needed to assess an individual's degree of lipid peroxidation which could
be a powerful predictor of cardiovascular disease risk. 8-lsoprostane is a
chemically stable prostanoid resulting from free radical catalyzed peroxida-
tion of arachidonic acid. This molecule is produced by oxidation of low den-
sity lipoprotein and is present in both plasma and urine. To evaluate this novel
marker of in vivo lipid peroxidation, we compared 24 hour urinary levels of
8-isoprostane in healthy smokers (n = 15) and nonsmokers (n = 9) with a
competitive enzyme immunoassay. Serum was also obtained for analysis of
lipid and antioxidant vitamin levels. Smokers were found to have higher lev-
els of urinary 8-isoprostane than nonsmokers and these levels were inversely
correlated with serum beta carotene (P = 0.04, r = -0.44) and vitamin C (P
= 0.01, r = -0.52). No significant differences were detected in lipid profiles
between smokers and nonsmokers.
Risk ratios were estimated for each group using Group 1 as a reference
and were only significantly elevated for Group 4 (2.6 ± 0.3; p < 0.0011. The
findings of this prospective study indicate that high fibrinogen levels are as-
sociated with a greater risk of IHD and that risk is associated with high Lp(a)
levels.
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A Telemedicine Arrhythmia Analysis Tool for
Rural Physicians
David A. Tong, Lawrence E. Widman. University of Oklahoma Health Sciences Center,
Oklahoma City, OK
Introduction; Rural health care practitioners are often faced with the task of
interpreting complex heart rhythms. Usually these practitioners do not have
specialized training in cardiology or ECG interpretation and available com-
mercial systems for interpreting 12-lead ECG have been well-documented
to perform rhythm analysis poorly. A computer-based tool is being devel-
oped in our laboratory that will provide rural health care practitioners with an
automated system for interpreting complex arrhythmias.
Methods: A prototype system was developed using resources readily
available in on the Internet: NCSA Mosaic, a hypermedia document browser;
NCSA Collage, an interactive distributed white-board system; and GNU
Ghostscript/Ghostview, a PostScript language interpretation system. The
prototype was created by modifying and integrating the functionality of the
individual systems into a single, easy to use system. The prototype was de-
veloped in C on UNIX workstations using the X display protocol and is based
on the client-server model. The system may be accessed by any computer
on the Internet with X display capability.
On the client side, the system assists the user in scanning an ECG, identi-
fying the waves in the scanned ECG, and transmitting the scanned ECG and
annotations to the server. On the server side, the system analyzes the anno-
tations using an knowledge-based rhythm analysis system being developed
in our laboratory. The system produces a PostScript file containing the in-
terpretation(s) and accompanying ladder diagrams and a case-specific help
file containing detailed descriptions and therapeutic indications. These files
are transmitted back to the user's computer and displayed to the user by the
client-side of the system. The design of the system provides for an "on-line,"
interactive consultation with a cardiologist.
Results: Development of the prototype system required 2.5 man-months
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1710-1 1 Changing Perspectives in Vein Graft Angioplasty
John S. Douglas Jr, William S. Weintraub, Spencer B. King III. Emory University
School ofMedicine, Atfanta, GA
In recent years angioplasty has been used increasingly in patients with more
severe disease. Technological improvements, including new interventional
devices has also changed the practice of interventional cardiology. To deter-
mine the impact of these changes on intervention in vein grafts, the results
of intervention in 1284 patients undergoing procedures between 1980 and
1993 were reviewed. Results (mean or %):
Year 80-2 83-4 85-6 87--8 89-0 91-2 93 P
n 52 112 99 191 299 359 172
Age 55 57 60 62 62 64 65 <0.0001
3 VDILM 46% 29% 42% 62% 53% 67% 69% <0.0001
EF 63 60 53 54 50 51 49 <0.0001
PriorMI 39% 49% 52% 62% 63% 56% 60% 0.009
New Dev a a a 1% 11% 35% 27% <0.0001
%DS Pre 80 78 78 77 77 80 81 0003
%DS Post 33 27 27 29 26 17 17 <0.0001
Ang Succ 81% 89% 84% 85% 88% 96% 94% <0.0001
OMI 1,9% 2.7% 3.0% 0.5% 2.3% 0.8% 1.8% NS
CABG 3.8% 1.8% 4.0% 2.6% 3.3% 0.8% 2.4% NS
Death a a 3.0% 1.0% 1.3% 1.4% 1.2% NS
Vein graft interventions have become more common. Despite an older and
